drugset / Trial / NCT00825266
Insulin Resistance in Pulmonary Arterial Hypertension
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to evaluate 1) the incidence of insulin resistance (a pre-diabetic state) in patients with pulmonary hypertension, and 2) test the utility of a validated PH therapy (Tracleer) versus Pioglitazone in the treatment of those patients found to have insulin resistance.
Timeline
- Start
- 2008-09
- Primary completion
- 2010-05
- Completion
- 2010-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Bosentan | Other / unclassified | 125 mg | — |
| Comparator | Pioglitazone | Small molecule | 30 mg | — |